Immune Therapeutics, Inc. Contracts & Agreements

108 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022
Note Agreements
Immune Therapeutics, Inc.
2024
Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022
Settlement Agreements
Immune Therapeutics, Inc.
2024
Executive Consulting Agreement, dated July 25, 2023, between Immune Therapeutics, Inc. and Noreen Griffin
Consulting Agreements
Immune Therapeutics, Inc.
2023
Amendment No. 1 to Executive Consulting Agreement between the Company and Kelly O. Wilson dated April 12, 2023
Consulting Agreements
Immune Therapeutics, Inc.
2023
Settlement Agreement between the Company and Statera Biopharma, Inc. dated April 12, 2023
Settlement Agreements
Immune Therapeutics, Inc.
Biotechnology
2023
Amendment No. 3 to License Agreement between the Company and Statera Biopharma, Inc. dated April 15, 2023
License Agreements
Immune Therapeutics, Inc.
2023
First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2023
Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022
Settlement Agreements
Immune Therapeutics, Inc.
2023
Consulting Agreement, dated November 1, 2022, between Immune Therapeutics, Inc. and Kelly O. Wilson
Consulting Agreements
Immune Therapeutics, Inc.
2022
Consulting Agreement, dated November 1, 2022, between Immune Therapeutics, Inc. and Glen Farmer
Consulting Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Intellectual Property License Agreement, dated September 30, 2022, between Immune Therapeutics, Inc. and TaiwainJ Pharmaceuticals Co. Ltd
License Agreements
Immune Therapeutics, Inc.
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
2022
Convertible Promissory Note in the Principal Amount of $200,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Separation and Release Agreement, dated July 19, 2022, between Kevin Phelps and Immune Therapeutics, Inc
Separation Agreements
Immune Therapeutics, Inc.
2022
Term Sheet
Term Sheets
Immune Therapeutics, Inc.
Biotechnology
2022
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
2022
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey
Exchange Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
2022
[REVISED CYTOCOM AGREEMENT]
Immune Therapeutics, Inc.
2021
Letter of Intent, dated May 25, 2021
Immune Therapeutics, Inc.
Biotechnology
2021
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
2021
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey
Exchange Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
2021
Agreement dated August 12, 2020 between Immune Therapeutics, Inc. and Cytocom, Inc. assigning all of .Immune Therapeutics right, title and interest in LDN and MENK in Developing...
License Agreements
Immune Therapeutics, Inc.
2020
Amendment to the Articles of Incorporation filed February 5, 2020 approving a reverse split of issued and outstanding shares of common stock by 1,000 to 1
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
2020
Amendment to the Articles of Incorporation filed March 12, 2020 approving an increase in authorized shares of common stock from 500,000,000 to 750,000,000
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
2020
Short-form Executive Employment Agreement dated July 22, 2020
Employment Agreements
Immune Therapeutics, Inc.
2020
Board Resolution dated July 24, 2020
Immune Therapeutics, Inc.
Biotechnology
2020
Securities Purchase Agreement dated as of May 4, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
2020
Securities Purchase Agreement dated as of June 15, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of...
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Amendment to Articles of Incorporation filed with the State of Florida on February 6, 2020, together with the Corporate Resolution of the Board of Directors dated February 2, 2020...
Articles of Amendment
Immune Therapeutics, Inc.
2020
Amendment to Articles of Incorporation filed with the State of Florida on March 12, 2020, 2020
Articles of Amendment
Immune Therapeutics, Inc.
2020
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
2020
Second Amendment to License Agreement with Cytocom Inc., effective December 31, 2018 and signed April 8, 2019
License Agreements
Immune Therapeutics, Inc.
Biotechnology
2020
License Agreement dated January 15, 2020 with Forte Biotechnology Intl. Corp
License Agreements
Immune Therapeutics, Inc.
Biotechnology
CO
2020
Convertible Promissory Note dated March 30, 2020 to Redstart Holdings Corp. in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
PRC Amendment to The Second Amendment to the License Agreement effective December 31, 2018 with Cytocom, Inc. and signed May 12, 2020
License Agreements
Immune Therapeutics, Inc.
2020
Mutual Release and Non-Disparagement Agreement effective April 30, 2020
Release Agreements
Immune Therapeutics, Inc.
2020
Board Resolution dated April 30, 2020
Immune Therapeutics, Inc.
2020
Letter of Intent dated March 17, 2020
Immune Therapeutics, Inc.
Biotechnology
FL
2020
Board Resolution
Immune Therapeutics, Inc.
2020
Employment Agreement with Michael Handley
Employment Agreements
Immune Therapeutics, Inc.
Biotechnology
DE
2019
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
2019
Second Amendment to License Agreement by and between: Cytocom Inc. and Immune Therapeutics Inc., signed April 8, 2019
License Agreements
Immune Therapeutics, Inc.
Biotechnology
2019
Letter to Shareholders
Shareholders Agreements
Immune Therapeutics, Inc.
Biotechnology
2019
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
2019
Restated Agreement
Immune Therapeutics, Inc.
2018
Stock Agreement
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2018
Loan agreement and promissory note with Joel Yanowitz, dated January 9, 2018, for $50,000
Loan Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2018
Loan agreement and promissory note with Rogoff Family Trust, dated February 13, 2018, for $50,000
Loan Agreements
Immune Therapeutics, Inc.
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $399,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $400,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Services Agreement, dated December 15, 2014, between Immune Therapeutics, Inc. and Aronstam Management Services, Inc
Management Agreements
Immune Therapeutics, Inc.
2018
Real Property Leases for Florida Office and Extensions dated July 19, 2017 and November 13, 2017
Immune Therapeutics, Inc.
2018
Extension of Employment Agreement with Noreen Griffin dated March 9, 2018
Employment Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Extension of AHAR Agreement dated March 29, 2016
Immune Therapeutics, Inc.
Biotechnology
2018
Extension of Employment Agreement with Peter Aronstam dated July 1, 2017
Employment Agreements
Immune Therapeutics, Inc.
2018
Consulting Agreement with Joyce Banda dated September 1, 2016
Consulting Agreements
Immune Therapeutics, Inc.
2018
Intellectual Property Assignment Agreement with Cytocom, Inc. dated September 4, 2015
Assignment Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Consulting Master Services Agreement with Cot Orphan, LLC dated February 16, 2016
Consulting Agreements
Immune Therapeutics, Inc.
2018
Securities Purchase Agreement and related agreements with JMJ Financial dated April 12, 2016 (filed as Exhibit 10.1 to our Current Report 8-K on April 18, 2016, and incorporated...
Purchase Agreements
Immune Therapeutics, Inc.
2018
Patent License Agreement dated September 24, 2014 between Dr. Jill P. Smith, LDN Research Group LLC and Cytocom, Inc. and related agreements
License Agreements
Immune Therapeutics, Inc.
2018
Promissory Note dated February 6, 2017 issued to Phoenix Fund Management, LLC
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Settlement agreement with Phoenix Fund Management, LLC dated February 28, 2017
Settlement Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Settlement agreement with Mr. Marshall Faulk dated April 3, 2017
Settlement Agreements
Immune Therapeutics, Inc.
2018
Promissory Note dated April 5, 2017 to Robert J. Dailey in the principal amount of $150,000
Note Agreements
Immune Therapeutics, Inc.
2018
Securities Purchase Agreement and Warrant dated May 1, 2017 with Ira Gaines
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Distribution Agreement with TNI BioTech International Ltd. and Omaera Pharmaceuticals Ltd. Dated August 22, 2017
Distribution Agreements
Immune Therapeutics, Inc.
2018
Settlement and mutual release agreement dated October 12, 2017 with Phoenix Fund Management, LLC and Far East Holdings, LLC
Settlement Agreements
Immune Therapeutics, Inc.
2018
Securities Purchase Agreement dated October 25, 2017 with Iliad Research and Trading, L.P
Purchase Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Iliad Research and Trading (i) promissory note and (ii) warrant dated October 25, 2017
Warrant Agreements
Immune Therapeutics, Inc.
2018
Independent Corporate Development and Consulting Agreement with CSJ Group, LLC, and Advanced BioStrategies, Inc. dated December 5, 2017
Consulting Agreements
Immune Therapeutics, Inc.
2018
Independent Corporate Development and Legal Advising Agreement with CSJ and August Strategic & Legal Advisors, Inc. dated December 6, 2017
Development Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement and Note with Iliad Research & Trading LP dated October 20, 2017
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2017
Settlement and Mutual Release Agreement with Phoenix Fund Management, LLC dated October 12, 2017
Settlement Agreements
Immune Therapeutics, Inc.
Biotechnology
2017
Distribution Agreement with Omaera Pharmaceuticals Ltd. dated August 22, 2017
Distribution Agreements
Immune Therapeutics, Inc.
2017
ADDENDUMTO COMMONSTOCK PURCHASE WARRANT DOCUMENTW-04122016
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2016
CONTRACTFOR THE MANUFACTURING OF PHARMACEUTICAL PRODUCTS
Immune Therapeutics, Inc.
Biotechnology
2016
EXCLUSIVEAGENCY AGREEMENT
Immune Therapeutics, Inc.
2016
ADDENDUMTO COMMONSTOCK PURCHASE WARRANT DOCUMENTW-04122016
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2016
EMPLOYMENTAGREEMENT
Immune Therapeutics, Inc.
2016
CONTRACTFOR THE COMPOUNDING OF PHARMACEUTICAL PRODUCTS
Immune Therapeutics, Inc.
Biotechnology
FL
2016
LODONAL" IN THE TREATMENT OF SUBJECTS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) A Bridging Study to Evaluate the Effects of LODONAL" as an Immune-System Regulating Agent in Subjects...
Immune Therapeutics, Inc.
Biotechnology
2015
ROYALTY AGREEMENT
Immune Therapeutics, Inc.
Biotechnology
FL
2015
PROMISSORY NOTE SETTLEMENT AGREEMENT
Note Agreements
Immune Therapeutics, Inc.
2015
PROMISSORY NOTE SETTLEMENT AGREEMENT
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2015
SERVICES AGREEMENT
Services Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2015
CONSULTING AGREEMENT
Consulting Agreements
Immune Therapeutics, Inc.
2015
Contract for the Compounding of Pharmaceutical Products, dated December 8, 2014
Immune Therapeutics, Inc.
Biotechnology
2014
Exhibit 10.1 Clinical Trial Agreement dated October 20, 2014 between TNI BioTech International Ltd. and American Hospital and Resorts
Immune Therapeutics, Inc.
2014
Exhibit 1.1 Supplementary Agreement on New Drug Methionine Enkephalin Cooperation, dated August 6, 2014, between TNI BioTech, Inc. and Hubei Qianjiang Pharmaceutical Co., Ltd
Cooperation Agreements
Immune Therapeutics, Inc.
2014
Exhibit 1.2 Assignment by Professor Fengping Shan Ph.D. to the Company, executed August 6, 2014
Assignment Agreements
Immune Therapeutics, Inc.
2014
Exhibit 1.1 Distribution Agreement, dated June 11, 2014, between Airmed Biopharma Limited and PanAm Global Logistics, Inc
Distribution Agreements
Immune Therapeutics, Inc.
2014
Promissory note to Robert J. Dailey, issued February 6, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
2014
Promissory note to Robert J. Dailey, issued March 7, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2014
Promissory note to Robert J. Dailey, issued March 28, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2014
Employment Agreement between Cytocom, Inc. and Dr. Graham Burton dated April 1, 2014
Employment Agreements
Immune Therapeutics, Inc.
Biotechnology
2014
Employment Agreement between Cytocom, Inc. and Gary Gemignani dated April 1, 2014
Employment Agreements
Immune Therapeutics, Inc.
Biotechnology
2014
Exhibit 10.16 1 2 3 4 5 6 7
Immune Therapeutics, Inc.
Biotechnology
2014
Exhibit 10.17
Immune Therapeutics, Inc.
2014
DISTRIBUTION AGREEMENT
Distribution Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2014
DISTRIBUTION AGREEMENT
Distribution Agreements
Immune Therapeutics, Inc.
2013